Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

Cancer

Volumn 91, Issue 2, 2001, Pages 333-338

  Kokawa, Atsushi ^a   Kondo, Hitoshi ^a   Gotoda, Takuji ^a   Ono, Hiroyuki ^b   Saito, Daizo ^b   Nakadaira, Saori ^b   Kosuge, Tomoo ^b   Yoshida, Shigeaki ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Cyclooxygenase; Intraductal papillary mucinous tumor; Pancreatic duct cell carcinoma

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0035863223     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N     Document Type: Article

References (40)

1. Preoperative staging and assessment of resectability of pancreatic cancer
2. The National Cancer Data Base report on pancreatic cancer
3. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
4. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
5. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells
6. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas
7. Molecular cloning of human prostaglandin endoperoxide synthases type II and demonstration of expression in response to cytokines
8. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
9. Prostaglandin endoperoxide synthase: Why two isoforms?
10. Aspirin and the risk of colorectal cancer in women
11. Reduced risk of large-bowel adenomas among aspirin users
12. Aspirin use and reduced risk of fatal colon cancer
13. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer
14. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
15. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
16. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
17. Elevated cyclooxygenase-2 levels in Min mouse adenomas
18. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells
19. Histological typing of tumours of the exocrine pancreas
20. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
21. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
22. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
23. Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours
24. Expression of cyclooxygenase-2 in human gastric carcinoma
25. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
26. Differential expression and regulation of cyclooxygenase-1 and -2 in human breast cancer cell lines
27. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: Association of COX-2 expression with human keratinocyte differentiation
28. Chemopreventive effects of Nimesulide, a selective cyclooxgenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl- N-(4-hydroxybutyl)nitrosamine
29. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
30. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
31. Prevalence of activating K-ras mutation in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas
32. c-Ki-ras point mutation in ductectatic-type mucinous cystic neoplasms of the pancreas
33. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
34. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production
35. Alterations in cellular adhesion and apotosis in epithelial cells overexpressing prostaglandin and endoperoxidase synthase 2
36. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
37. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment
38. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adeno-carcinoma cells: Effects on cell cycle and apotosis
39. Apotosis induced by NS-398, a selective cyclooxtgenase-2 inhibitor, in human colorectal cancer cell lines